Bhagawati Oxygen Ltd to Consider Q2 FY27 Results on Nov 13

Bhagawati Oxygen Ltd will consider its unaudited Q2 FY27 and first-half FY27 financial results on 13 November 2026, following a ₹0.33 crore standalone net loss and ₹0.13 crore sales in the quarter ended 30 June 2026. The board meeting will cover the quarter and half-year ended 30 September 2026.

When will Bhagawati Oxygen Ltd report Q2 FY27 results?

Bhagawati Oxygen Ltd is scheduled to hold a board meeting on 13 November 2026 to consider and approve unaudited financial results for the quarter and half-year ended 30 September 2026. The scheduled disclosure is the company’s Q2 FY27 earnings update and will also provide H1 FY27 financial data.

The board agenda states that other items may also be considered as per the meeting agenda. No Q2 revenue, profit, margin or balance-sheet figures have been provided ahead of the meeting. Investors will therefore need to wait for the board-approved financial results and related exchange filing for the reported numbers.

The company had previously scheduled a board meeting on 14 August 2026 for its Q1 FY27 financial results. Its latest reported June-quarter performance establishes the immediate comparison point for the forthcoming September-quarter disclosure.

What did Bhagawati Oxygen Ltd report in Q1 FY27?

Bhagawati Oxygen Ltd reported sales of ₹0.13 crore and a net loss of ₹0.33 crore for the quarter ended 30 June 2026. Sales were 13.33% lower than ₹0.15 crore in the quarter ended 30 June 2025, while the loss widened from ₹0.03 crore in the year-earlier quarter.

The quarterly data also showed expenses of ₹0.55 crore in June 2026, compared with ₹0.43 crore in June 2025. Higher expenses than sales resulted in an operating loss, with the provided quarterly figures showing an operating loss of ₹0.34 crore for the June 2026 quarter.

The June quarter followed an unusual March 2026 quarter, when the company reported sales of ₹0.01 crore and net profit of ₹3.26 crore. The difference between low reported sales and the March-quarter profit means the composition of income and expenses, including any non-operating items disclosed in the financial statements, will be relevant when assessing the company’s earnings trend.

How did Bhagawati Oxygen Ltd perform in FY26?

Bhagawati Oxygen Ltd reported FY26 revenue of ₹5.17 crore, operating profit of ₹3.35 crore and net profit of ₹3.27 crore. The corresponding FY25 figures were revenue of ₹1.68 crore, operating profit of ₹0.51 crore and net profit of ₹0.45 crore.

On the figures provided, revenue rose 207.74% year on year in FY26, while operating profit increased 756.86% and net profit increased 826.67%. The annual result marked a return to profit compared with the level of profit reported in FY25.

However, the June-quarter loss shows that the annual FY26 performance should be considered alongside quarterly volatility. The March 2026 quarter accounted for ₹3.26 crore of net profit in the quarterly series provided, whereas the June 2026 quarter moved back into a loss. The Q2 and H1 results will give a more current view of reported operating performance.

What should investors review in the Q2 FY27 filing?

Investors should review Bhagawati Oxygen Ltd’s September-quarter sales, expenses, operating result and net profit or loss when the filing is released. Comparing these figures with the June 2026 quarter and the September 2025 quarter will help establish whether the company’s reported sales and cost base have changed.

The half-year statement will also be important because it combines the June and September quarters. Given the FY26 profit and the Q1 FY27 loss, readers should examine notes to the financial statements for the nature of income and expenses, as well as any disclosures that explain significant movements in profit.

Bhagawati Oxygen Ltd operates in the industrial gases and fuels segment and is described as an India-based gas manufacturing and trading company, with its head office in Ballabhgarh. For a company with small quarterly sales in the reported figures, movements in individual income or expense items can have a material effect on margins and profit or loss.

How could the results matter to Bhagawati Oxygen Ltd shareholders?

The 13 November board meeting is a defined near-term disclosure event for Bhagawati Oxygen Ltd shareholders because it will update the market on Q2 FY27 and H1 FY27 financial performance. The release will provide official figures for the September period, which are not available in the supplied information before the meeting.

The financial update also matters because the company’s reported quarterly results have varied sharply. The supplied series shows net losses of ₹0.19 crore in September 2024, ₹0.21 crore in December 2024, ₹0.03 crore in June 2025, ₹0.08 crore in December 2025 and ₹0.33 crore in June 2026, alongside profits in some other quarters.

Investors should distinguish between reported revenue, operating profit or loss and net profit or loss rather than relying on a single metric. The board-approved results, along with any accompanying limited-review information and notes, will be the primary source for assessing the September quarter.

Conclusion

Bhagawati Oxygen Ltd is due to consider Q2 FY27 and H1 FY27 unaudited results on 13 November 2026 after a June-quarter net loss of ₹0.33 crore on sales of ₹0.13 crore. The filing is significant because it will follow a FY26 in which the company reported ₹3.27 crore net profit, but also a return to a quarterly loss in Q1 FY27.

The next item to watch is the board-approved disclosure for the quarter and half-year ended 30 September 2026. Investors can compare its reported sales, expenses, operating result and net result with the June 2026 quarter and review the notes for explanations of material changes in earnings.